Filing Flows › Sanofi (SNY) › FY2024
Sanofi (SNY) FY2024 earnings results (fiscal 2024)
20-F filed Feb 13, 2025
Sanofi (SNY) reported revenue of $41.1B for the fiscal 2024 (FY2024), +9% from a year earlier. Operating margin was 17.7%, net earnings $5.6B (13.5% of revenue).
Sanofi, FY2024: revenue $41.1B (+9% year over year), operating margin 17.7%, net earnings $5.6B, operating cash flow $9.1B. The chart follows the revenue to costs, profit and cash.
| FY2024 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $41.1B | — | +9% |
| Gross profit | $31.1B | — | +7% |
| Operating profit | $7.3B | — | +4% |
| Net earnings | $5.6B | — | +3% |
| Operating cash flow | $9.1B | — | -11% |
What changed
Revenue was €41.1B in FY2024, up 9% year over year.
Gross margin was 75.7%, down 1.0 points from FY2023. Operating profit was €7.3B, a 17.7% margin (down 0.8 points year over year). Of the extra revenue versus FY2023, 9% reached operating profit, below the 18% margin then. Operating expenses grew 8% against revenue growth of 9%. The fastest-growing cost line was Research & development (+14%). Net earnings were €5.6B, up 3% year over year. The effective tax rate was 17.6%.
Operating cash flow was €9.1B (down 11% year over year), 162% of net earnings. Non-cash charges added back €0.28B of share-based compensation. Working capital and other items added €3.2B.
Questions
What was Sanofi's revenue in the fiscal 2024?
Sanofi (SNY) reported revenue of $41.1B for the fiscal 2024 (FY2024), +9% from a year earlier.
Was Sanofi profitable in the fiscal 2024?
Operating profit was $7.3B (17.7% of revenue) and net earnings $5.6B.
Source: Sanofi 20-F on SEC EDGAR.